New Delhi, Aug 10 : The Centre Wednesday approved biological E’s Corbevax as a heterologous preventive dose for adults over 18 years of age for usage with two doses of either Covishield or Covaxin the source said.According to the report the source, the Corbevax vaccine can be considered a precautionary dose following the completion of 6 months or 26 weeks after the date of the administration of the second dose of either Covaxin or Covishield vaccines.
In the meantime, India on Wednesday reported 16,047 new cases of Covid-19 in the past 24 hours.
In the same time there were an additional 54 deaths, bringing the total death toll up to 5,26,826.
avr/
